medigraphic.com

2010, Number 4

<< Back Next >>

Rev Fac Med UNAM 2010; 53 (4)

Metabolic syndrome in a 6 to 16 years old population at basic level of attention

Bautista-Samperio L, Saldaña CMM, Hernández-Pérez JC

Language: Spanish
References: 22
Page: 3-8
PDF size: 224.83 Kb.


ABSTRACT

Introduction: The metabolic syndrome (SM), implies the association of factors of risk, obesity, diabetes mellitus, arterial hypertension, whose physiopathological factor (resistance to the insulin and atherogenic effect), causes a high cardiovascular risk. Its prevalence in children between 6 to 14 years, is of 18,6% and 30% in Spain and the United States respectively; Mexico in the population between 5 to 11 years reports obesity in 26% without integrating this syndrome.
Objective: To determine the frequency of the SM in population of 6 to 16 years of age, taken care of in familiar medicine.
Material and methods: Cross-sectional study, in 150 individuals of the UMF 94 of the Instituto Mexicano del Seguro Social (IMSS), both sexes, between 6 and 16 years of age, healthy, with sampling by 6 convenience and consent apparently informed. Applying clinical history with deliberate search of risk factors, clinical elements (arterial tension, index of corporal mass, acne and acantosis) and chemicals (glucose, cholesterol and triglycerides) in peripheral blood. Comparing values with tables of the Centers Disease Control (CDC) and National High Blood Pressure Education Program in Children and Adolescents. Analysis with descriptive statistic and coefficient of correlation of Tau and Phi.
Results: Of 150 participants, they reported familiar antecedent 127 (85%), obesity 48 (32%), arterial tension elevated 20 (30%), acantosis 28 (19%) and acne 5 (7%), hipertrigliceridemia 93 (62%) and hipercolesterolemia 35 (23%). SM in 50 (33%) with significant influence of sex and presence ofobesity was integrated.
Conclusions: The high frequency of the SM, with significant influence of sex and obesity in children population apparently heals, fortifies its deliberate search by health professionals.


REFERENCES

  1. Quibrera-Infante R. Concepto e historia del síndrome metabólico. En: González-Chávez A, Lavalle GF, Ríos GJ, editores. Síndrome metabólico y enfermedad cardiovascular. México: Intersistemas SA de CV, 2004: vol (1):01-06.

  2. Cabalé VM, Sánchez SD, Flores SA. Prevalencia del síndrome metabólico en dislipidémicos. Rev Cub Med [en línea]. 2006; Jul-Sep [acceso Sep 2006]: 45(3). Disponible en: http:// bvs.sld.cu/revistas/med/vol45_3_06/med04306.htm

  3. Lerman GI, Aguilar-Salinas CA, Gómez PFJ, Reza AA, Hernández JS, Vásquez CC, et al. Posición de la Sociedad Mexicana de Nutrición y Endocrinología, sobre la definición, fisiopatología y diagnóstico. Características del síndrome metabólico en México. Rev Endocrinol y Nutr. 2004;12(3):109-22.

  4. Rodríguez PAM. Enfoque actual: Síndrome metabólica. Rev Cub Endocrinol. 2002;13(3):238-52.

  5. Rivera J, Cuevas L, Shamah T, Villalpando S, Ávila MA, Jiménez A. Estado nutricio. En: Olaiz G, Rivera J, Shamah T, Rojas R, Villalpando S, Hernández M, et al, editores. Encuesta nacional de salud y nutrición. México, 2006: 85- 103.

  6. Ceballos L, López J, Jurado A. Prevalencia del síndrome metabólico y sus componentes en niños y adolescentes con obesidad. An Pediatr. 2007;67 (4):352- 61.

  7. Cruz M L, Weigebsberg MJ, Huang TT, Ball G, Shaibi GQ, Golan MI. The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity. J Clin endocrinol metab. 2004;89(1):108-13.

  8. Romero-Velarde E, Campollo-Rivas O, Celis de la Rosa A, Vásquez-Garibay E, Castro-Hernández J, Cruz-Osorio R. Factores de riesgo de dislipidemia en niños y adolescentes con obesidad. Salud pública de México. 2007;49(2):103-8.

  9. Consenso mexicano de resistencia a la insulina y síndrome metabólico. Rev Mex Cardiol. 1999;10(1):3-19.

  10. Gregory B. Luma, M.D. Roseann T. Spiotta, M.D. Hypertension in children and adolescents. Am Fam Physician. 2006; 73(9):1558-68.

  11. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. National high blood pressure education program working group on high blood pressure in children and adolescents. Official journal of the American Academy of Pediatrics. Disponible en: http:// pediatrics.aappublications.org/cgi/reprint/114/2/s2/555

  12. Gómez QL. Validez de cuatro glucómetros portátiles para su uso en atención primaria. Medicina de Familia. 2002;2(2):128-32.

  13. Calderín O, Prieto M, Cabrera E. Síndrome de insulinorresistencia en niños y adolescentes. Rev Cub Endocrinol [en línea]. 2007;May-Jun [Acceso Abril 2007];18(2). Disponible en: http://bvs.sld.cu/revistas/end/vol18_2_07/end07207.html.

  14. Aranibar-Machaca JS. Acantosis nigricans e hiperinsulinemia en niños y adolescentes obesos del Instituto Nacional de Salud del Niño. Paediatrica. 2006;8(1):64-7.

  15. Juárez I, Anaya M, Mejía J, Games J, Sciandra M, Núñez F, Herrera J, et al. Niveles séricos de colesterol y lipoproteínas y frecuencia de hipercolesterolemia en un grupo de adolescentes de la Ciudad de México. Bol. Med. Hosp. Infant. Méx. 2006;63(3):162-68.

  16. Weiss R, Dziura J, Burgert T, Tamborlane W, Taksali S, Yeckel C, et al. Obesity and the Metabolic Syndrome in Children and Adolescents. N. Engl. J. Med. 2004;350:2362-74.

  17. Muñoz HO, Gutiérrez TG, Méndez BJ, Borja AV, Guarneros ChA, Zurita GB, el al. Programas integrados de salud. Rev. Enferm. IMSS. 2005;13(1):41-56.

  18. Pajuelo J, Rocca J, Gamarra M. Obesidad infantil: sus características antropométricas y bioquímicas. Anuario Fac. Med. 2003;64(pt 1):21-6.

  19. Cruz M, Goran M. The metabolic syndrome in children and adolescents. Disponible en: http://www-hsc.usc. edu/~goran/PDF%20papers/R35.pdf.

  20. Instituto Nacional de Salud Pública. Encuesta Nacional de Salud 2000. México: Secretaría de Salud; 2003. 94-128.




2020     |     www.medigraphic.com